Novartis Pharmaceuticals Corporation

Registered Principal Details

Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.

Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.

CEO Name:
Ludwig Hatson
Director, Public Affairs Operations

Contact
KH
Kathy-Jo Hayden
One Health Plaza
East Hanover, NJ 07936-1080
(862) 778-2585
(973) 781-6671
kathy-jo.hayden@novartis.com
www.novartis.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Scott Stenger Exclusive Duties N/A Authorized On 1/13/2009 Withdrawn On N/A
Mindy Walker Exclusive Duties N/A Authorized On 1/13/2009 Withdrawn On N/A
Lisa Steelman Exclusive Duties N/A Authorized On 5/13/2010 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 56
Assembly Bill 56
Relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
3/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health and Family Services: Departmentwide and Management and Technology
Biennial budget bill treatment of matter relating to
Health and Family Services: Departmentwide and Management and Technology

Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Development, drafting or introduction of a proposal relating to Prescription Drugs
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to Prescription Drugs

Action Intended To Affect
Legislative Matter

Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Development, drafting or introduction of a proposal relating to Prescription Drugs
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to Prescription Drugs

Action Intended To Affect
Legislative Matter

Notification Date
1/28/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Pharmaceutical companies
Development, drafting or introduction of a proposal relating to
Pharmaceutical companies

Action Intended To Affect
Legislative Matter

Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Prescription Drugs.
Development, drafting or introduction of a proposal relating to
Prescription Drugs.

Action Intended To Affect
Legislative Matter

Notification Date
2/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Prior authorization of prescription drugs
Development, drafting or introduction of a proposal relating to
Prior authorization of prescription drugs

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
3/30/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
Total Lobbying Expenditures 2009
January - June
$16,450.00
2009
July - December
$0.00
2010
January - June
$0.00
2010
July - December
$0.00
Total $16,450.00
Total Hours Communicating 2009
January - June
1.50
2009
July - December
0.00
2010
January - June
0.00
2010
July - December
0.00
Total 1.50
Total Hours Other 2009
January - June
30.75
2009
July - December
10.50
2010
January - June
0.00
2010
July - December
0.00
Total 41.25

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: advertising for prescription drugs.
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
50 %
2009
July - December
2010
January - June
2010
July - December
Total 37 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
50 %
2009
July - December
2010
January - June
2010
July - December
Total 38 %
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
50 %
2010
January - June
2010
July - December
Total 12 %

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
50 %
2010
January - June
2010
July - December
Total 12 %

Filed Statements of Lobbying Activity and Expenditures